Placebo‐Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV‐1 Infection
Top Cited Papers
Open Access
- 1 March 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 191 (5) , 654-665
- https://doi.org/10.1086/428404
Abstract
BackgroundA vaccine is needed to prevent human immunodeficiency virus type 1 (HIV-1) infectionMethodsA double-blind, randomized trial of a recombinanKeywords
This publication has 0 references indexed in Scilit: